185 related articles for article (PubMed ID: 31921641)
1. Long Non-coding RNA
Lv L; He L; Chen S; Yu Y; Che G; Tao X; Wang S; Jian Z; Zhang X
Front Oncol; 2019; 9():1383. PubMed ID: 31921641
[TBL] [Abstract][Full Text] [Related]
2. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
3. DNMT1-induced miR-133b suppression via methylation promotes myocardial fibrosis after myocardial infarction.
Zhang S; Xie H; Du Y; Wang B; Lan B; Wang H
Gen Physiol Biophys; 2023 Sep; 42(5):417-429. PubMed ID: 37702447
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells.
Lv LV; Zhou J; Lin C; Hu G; Yi LU; DU J; Gao K; Li X
Oncol Lett; 2015 Aug; 10(2):907-912. PubMed ID: 26622593
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0071589 aggravates stemness and oxaliplatin resistance in colorectal cancer through sponging miR-133b to upregulate SOX13 expression.
Lv L; Yi L; Huang B; Zhou C; Zhang L
Mol Cell Biochem; 2023 Jul; ():. PubMed ID: 37522976
[TBL] [Abstract][Full Text] [Related]
6. Facilitating colorectal cancer cell metastasis by targeted binding of long non-coding RNA ENSG00000231881 with miR-133b via VEGFC signaling pathway.
Zhou J; Zou Y; Hu G; Lin C; Guo Y; Gao K; Wu M
Biochem Biophys Res Commun; 2019 Jan; 509(1):1-7. PubMed ID: 30581003
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
[TBL] [Abstract][Full Text] [Related]
8. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.
Bhattacharjya S; Roy KS; Ganguly A; Sarkar S; Panda CK; Bhattacharyya D; Bhattacharyya NP; Roychoudhury S
Mol Cancer; 2015 Feb; 14():42. PubMed ID: 25743594
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
[TBL] [Abstract][Full Text] [Related]
11. MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.
Xiang KM; Li XR
Asian Pac J Cancer Prev; 2014; 15(8):3767-72. PubMed ID: 24870791
[TBL] [Abstract][Full Text] [Related]
12. LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1.
Liang W; Wu J; Qiu X
J Transl Med; 2021 Jan; 19(1):45. PubMed ID: 33499872
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
Wang H; Wu J; Meng X; Ying X; Zuo Y; Liu R; Pan Z; Kang T; Huang W
Carcinogenesis; 2011 Jul; 32(7):1033-42. PubMed ID: 21565830
[TBL] [Abstract][Full Text] [Related]
14. miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs.
Chen M; Li D; Gong N; Wu H; Su C; Xie C; Xiang H; Lin C; Li X
Oncotarget; 2017 Aug; 8(32):52983-52994. PubMed ID: 28881788
[TBL] [Abstract][Full Text] [Related]
15. lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer.
Xu M; Chen X; Lin K; Zeng K; Liu X; Xu X; Pan B; Xu T; Sun L; He B; Pan Y; Sun H; Wang S
J Hematol Oncol; 2019 Jan; 12(1):3. PubMed ID: 30626446
[TBL] [Abstract][Full Text] [Related]
16. EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines.
Liu Y; Yu J; Xie Y; Li M; Wang F; Zhang J; Qi J
Exp Ther Med; 2020 Nov; 20(5):33. PubMed ID: 32952624
[TBL] [Abstract][Full Text] [Related]
17. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
18. LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1.
Qin J; Li Y; Li Z; Qin X; Zhou X; Zhang H; Li S
Clin Epigenetics; 2022 Apr; 14(1):51. PubMed ID: 35414117
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BDNF-AS suppresses colorectal cancer cell proliferation and migration by epigenetically repressing GSK-3β expression.
Zhi H; Lian J
Cell Biochem Funct; 2019 Jul; 37(5):340-347. PubMed ID: 31062382
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
Li Z; Yang L; Liu X; Nie Z; Luo J
Biomed Pharmacother; 2018 Aug; 104():181-192. PubMed ID: 29772439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
